Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background. In 1999, meningococcal serogroup C conjugate (MCC) vaccines were introduced in the United Kingdom for those under 19 years of age. The impact of this intervention on asymptomatic carriage of meningococci was investigated to establish whether serogroup replacement or protection by herd immunity occurred. Methods. Multicenter surveys of carriage were conducted during vaccine introduction and on 2 successive years, resulting in a total of 48,309 samples, from which 8599 meningococci were isolated and characterized by genotyping and phenotyping. Results. A reduction in serogroup C carriage (rate ratio, 0.19) was observed that lasted at least 2 years with no evidence of serogroup replacement. Vaccine efficacy against carriage was 75%, and vaccination had a disproportionate impact on the carriage of sequence type (ST)-11 complex serogroup C meningococci that (rate ratio, 0.06); these meningococci also exhibited high rates of capsule expression. Conclusions. The impact of vaccination with MCC vaccine on the prevalence of carriage of group C meningococci was consistent with herd immunity. The high impact on the carriage of ST-11 complex serogroup C could be attributed to high levels of capsule expression. High vaccine efficacy against disease in young children, who were not protected long-term by the schedule initially used, is attributed to the high vaccine efficacy against carriage in older age groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The reduction in carriage lasted for at least 2 years after vaccine introduction, with no evidence of serogroup replacement (199).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The staden sequence analysis package
Staden, R. (1996) · Molecular Biotechnology · doi:10.1007/bf02900361 · Cited by 1,263
Multilocus Sequence Typing of Bacteria
Maiden, M. C. J. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121325 · Cited by 915
Self-citationEffectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571 · cited 1×
“This was fortuitous given that the infant schedule used for MCC vaccines in the United Kingdom at the time of vaccine introduction did not confer long term protection [27].”
BackgroundSelf-citationSequence type analysis and recombinational tests (START)
Jolley, K. A., Feil, E. J., Chan, M.-S., & Maiden, M. C. J. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.12.1230 · Cited by 512
Self-citationmlstdbNet – distributed multi-locus sequence typing (MLST) databases
Jolley, K. A., Chan, M.-S., & Maiden, M. C. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-86 · Cited by 501
Self-citationMiller, E., Salisbury, D., & Ramsay, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 482
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446
The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421
Self-citationMaiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · cited 4×
“bacteria [13], which, although rarely isolated from carriers, are”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- 12. Jelfs J, Munro R, Ashton F, Rawlinson W, Caugant DA. Global study of variation in a new variant of the ET-37 complex of Neisseria meningitidis. In: Program and abstracts of the 11th International Pathogenic Neisseria Conference. Nice, France: Editions E.D.K., 1998 :5.
Cited by
Items 401–488 of 488
Bacterial meningitis in adults: clinical characteristics, risk factors and adjunctive treatment
Brouwer, M. C. (2010) · UvA-DARE (University of Amsterdam) · Cited by 3
A molecular epidemiological analysis of meningococcal isolates within Scotland 1972-1998.
Sullivan, C. B. (2008) · Enlighten: Theses (The University of Glasgow) · Cited by 2
Tartof, S. Y., Cohn, A. C., Tarbangdo, F., Djingarey, M. H., Messonnier, N. E., Clark, T. A., Kambou, J. L., Novak, R. T., Diomandé, F. V. K., Médah, I., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190188 · Cited by 2
Currie, E. G., Rojas, O. L., Lee, I. S., Khaleghi, K., Martín, A., Gommerman, J. L., & Gray‐Owen, S. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.11.612551 · Cited by 2
Fine, P., Mulholland, K., Scott, J. A. G., & Edmunds, W. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00078-5 · Cited by 1
Examining the role of IgA in a persistent model of Staphylococcus aureus colonization
Pérez-Betancourt, Y., Shi, M., & Missiakas, D. M. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013924 · Cited by 1
Brouwer, M. C., & van de Beek, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-7959-7.00034-8 · Cited by 1
Loosening the grip of meningococcal disease in Africa
Elias, J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61898-x · Cited by 1
Meningococcal disease: diagnosis and prevention
Driver, C. (2013) · Primary Health Care · doi:10.7748/phc2013.03.23.2.32.e702 · Cited by 1
Badahdah, A.-M. M., Khatami, A., Tashani, M., Rashid, H., & Booy, R. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001861 · Cited by 1
Sales, N. M. M. D., Azevedo, J., Ribeiro, M. T. B., de Freitas, H. F., Filho, H. P. D. S., Cordeiro, S. M., dos Reis, M. G., & Reis, J. N. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.045 · Cited by 1
Cáceres, R., Guillén, J., González-Inchausti, C., & Sobrino, M. G. (2021) · Farmacéuticos Comunitarios · doi:10.33620/fc.2173-9218.(2021/vol13).004.05 · Cited by 1
Neri, A., Fabiani, M., Barbui, A. M., Vocale, C., Miglietta, A., Fazio, C., Carannante, A., Palmieri, A., Vacca, P., Ambrosio, L., et al. (2022) · Vaccines · doi:10.3390/vaccines10050778 · Cited by 1
Historical review of vaccination against meningococcus in Spain (1996–2021). Learned lessons
Valls-Arévalo, A., de Alba, A. F., López-Martín, D., Goycochea-Valdivia, W. A., Cano, I. M., de Villalta, M. G.-F., de la Cueva, I. S., & Garcés‐Sánchez, M. (2023) · Vacunas (English Edition) · doi:10.1016/j.vacune.2023.01.003 · Cited by 1
Meningococcal Vaccines Directed at Capsular Group B
Stephens, D. S., Granoff, D. M., Pollard, A. J., & Harrison, L. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00040-2 · Cited by 1
Peletiri, I. C., Nwachukwu, R. C. N. C., Peletiri, D. C., Onoja, E. Q., Tulagha, C. T., Igbalibo, I. I., Ayanbimpe, G. M., & Ikey, E. I. (2023) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v12i1.2086 · Cited by 1
Alqahtani, F. Y. (2012) · Nottingham ePrints (University of Nottingham) · Cited by 1
The role of fructose-1,6-bisphosphate aldolase (FBA) in the pathogenesis of Neisseria meningitidis
Shams, F. M. (2016) · Nottingham ePrints (University of Nottingham) · Cited by 1
Martin, N. G. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-8goeqoqje · Cited by 1
Qarani, S. M. (2016) · Nottingham ePrints (University of Nottingham) · Cited by 1
Genomic epidemiology of meningococcal vaccine antigens in the United Kingdom
Rodrigues, C. M. C. (2018) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-agn0jmbv6 · Cited by 1
Meningococcal Carriage, Disease and Vaccination
Badahdah, A.-M. M. (2019) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Maiden, M. C. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817114.ch3
Self-citationScott, K. J. (2011) · Enlighten: Theses (The University of Glasgow)
Varying vaccination schedules: do all roads lead to Rome?
Wiedermann, U. (2009) · Monatsschrift Kinderheilkunde
Adjuvants: an essential component of neisseria vaccines
Acevedo, R., Romeu, B., del Campo, J. M., Gonzáles, E., Balboa, J. A., Zayas, C., Cabrera, O., Lastre, M., Ferro, V. A., & Pérez, O. (2009) · Vaccimonitor/VacciMonitor
Schmidt, M. A. (2009) · Deep Blue (University of Michigan)
Childhood immunisation: Recent changes to the routine schedule
Ford, K. J. (2014) · Journal of Health Visiting · doi:10.12968/johv.2014.2.10.532
Zapobieganie zakażeniom meningokokowym – jak stosować obecnie dostępne szczepionki
Jackowska, T., Konior, R., Skoczyńska, A., Szenborn, L., & Wysocki, J. (2014) · Pediatria Polska · doi:10.1016/j.pepo.2014.01.001
Brehony, C. (2010) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-jb1xgxpdd
Recent changes to the routine childhood immunization schedule
Ford, K. J. (2015) · Practice Nursing · doi:10.12968/pnur.2015.26.8.386
polysaccharide in healthy adults.
Findlow, H., Borrow, R., Hardelid, P., Newton, E., Frankland, S., Naylor, S., & Kaczmarski, E. (2011)
Self-citationANNUAL REPORT OF THE AUSTRALIAN
Meningococcal Surveillance Programme (2010)
Prevention of serogroup B meningococcal disease
Fusar‐Poli, P., & Yung, A. R. (2012)
Mustapha, M. M. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Moodley, C. (2011) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Maintaining protection against invasive bacteria with protein- polysaccharide conjugate vaccines
Cohn, M. L., Libero, G. D., Gascoigne, N. R. J., Hoefer, T., Jameson, S. C., Luescher, I. F., Mallaun, M., & Mescher, M. F. (2009)
Faye, P. M., Camara, B., Fall, A. L., Diagne-Guèye, N. R., Cissé, M. F., Diagne, I., Bâ, M., & Sow, H. D. (2010) · Journal de Pédiatrie et de Puériculture · doi:10.1016/j.jpp.2010.08.007
Hung, M.-C. (2012) · ePrints Soton (University of Southampton)
Deidda, S. (2016) · UnissResearch (Università degli Studi di Sassari)
Brouwer, M. C., & van de Beek, D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-5101-2.00028-5
Secreted neisserial proteins as potential vaccines or tools for biotechnology
Harding, S. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
The population structure of bacterial pathogens
Watkins, E. (2015) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-vyxk8vvbg
Meningococcal genome dynamics: an allele based, population approach to define lineage structure
Bratcher, H. B. (2015) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-8gao8okyg
A Stochastic Model for Meningococcal Disease
Autio, H. (2017) · Lund University Publications Student Papers (Lund University)
Pneumococcal disease and the impact of pneumococcal conjugate vaccines
Wagenvoort, G. H. J. (2017) · Utrecht University Repository (Utrecht University)
Impacto da vacinação contra o meningococo C na morbidade da doença meningocócica
Tomich, L. G. M. D. M. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Clark, S. A. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32479248
Luiz, A. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-14082018-092541
The role of national surveillance data in meningococcal conjugate vaccine programmes in England
Campbell, H. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32479680
Claudia, C. S., Consuela, M., Simona, D., Raluca, M. S., Pînzaru, A. D., Florin, M., & Mihai, L. (2019) · Ars medica tomitana · doi:10.2478/arsm-2019-0029
Terranova, L. (2019) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/terranova-leonardo_phd2019-01-18
Novel Complement Blocking Antibodies Against Serogroup B N. meningitidis: A Dissertation
Ray, T. D. (2010) · eScholarship@UMassChan · doi:10.13028/kwp1-3r83
Meningococcal Vaccines of New Generations – the First 20 Years of Use
Kostyukova, N. N., & Va, B. (2021) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2021-20-4-103-113
García, Y. R., Abitbol, V., Pellegrini, M., Bekkat-Berkani, R., & Soumahoro, L. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00554-z
Control of serogroup W meningococcal disease outbreaks: the promise of adolescent vaccination
Mbaeyi, S. A., & McNamara, L. A. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00349-7
de Moraes, C. (2016) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2016.10.t.22773
(2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283300b10
Fonderflick, M. (2013) · Publications Et Travaux Academiques de Lorraine (Universite de Lorraine)
Leiritz, J.-C. (2011) · Publications Et Travaux Academiques de Lorraine (Universite de Lorraine)
Revisión histórica de la vacunación frente a meningococo en España (1996-2021). Lecciones aprendidas
Valls-Arévalo, A., de Alba, A. F., López-Martín, D., Goycochea-Valdivia, W. A., Cano, I. M., de Villalta, M. G.-F., de la Cueva, I. S., & Garcés‐Sánchez, M. (2022) · Vacunas · doi:10.1016/j.vacun.2022.10.003
Alghamdi, M. S., Samman, A., Zahrani, W. A., Qumri, F., Filmban, M., Jewaeher, T., Alghamdi, M., Alzahrani, A., AlGhamdi, G. S., Alkurmi, M., et al. (2023) · International journal of health research and innovation · doi:10.47260/ijhri/1111
The modulatory effects of commensal neisseriae on upper respiratory tract infections
Page, K. L. (2014) · UWE Research Repository (UWE Bristol)
de Lima, G. T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2020.tde-13092023-110326
(2024) · International Journal of Veterinary Science · doi:10.47278/book.cam/2024.259
Gruhn, S., Batram, M., Wick, M., Langevin, E., Scholz, S. M., Greiner, W., & Damm, O. (2025) · Infectious Diseases and Therapy · doi:10.1007/s40121-025-01132-3
Bezerra, D. C. B., Costa, F. D. O., Costa, Y. K. D. S., da Rocha, F. H. B. P., de Andrade, S. N. B., Siriano, T. P., da Silva, G. N., Lessa, A. B. B., Santos, M. M., dos Passos, A. R., et al. (2025) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2025v7n10p1468-1486
Jones, C. H., Li, Z., Hao, L., ENDE, A. V. D., Liberator, P., Anderson, A. S., & Murthy, A. K. (2025) · FEMS Microbiology Letters · doi:10.1093/femsle/fnaf140
Neisseria meningitidis: epidemiology and pertinence of the Portuguese vaccinal strategy
Monteiro, A. C. M. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/52pm-xz13
Rohner, G. B. (2008) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-nzreeb9bv
Controlled human infection with Neisseria lactamica
Gbesemete, D. F. (2024) · ePrints Soton (University of Southampton)
Macêdo, L. E. N. (2022) · Arca - Repositório Institucional da Fiocruz
Jördens, M. S. (2016) · Online Publication Service of Würzburg University (Würzburg University)
Akdeniz, M., & Erkek, N. (2016) · Klinik Tıp Aile Hekimliği
Bechini, A., Pieralli, F., Paolini, D., Boccalini, S., Nieddu, F., Moriondo, M., Azzari, C., & Bonanni, P. (2016) · Florence Research (University of Florence)
Determinants of Immunity against the Meningococcus
Currie, E. G. (2021) · TSpace (University of Toronto)
Alsaeed, M., Ahmad, S., Alanazi, K., Alibrahim, A., Alshehri, S., Alqurashi, M. M., Algarni, A., Shosha, D., Alabdullah, M. A., Alsharhan, Y., et al. (2026) · Mass gathering medicine. · doi:10.1016/j.mgmed.2026.100059
Sevestre, J. (2018) · theses.fr (ABES) · doi:10.70675/269fada9zf58cz4ad8zb125z8b1aa204c23e
Efficacité de la vaccination contre le méningocoque de type C : revue de la littérature
Ribollet, F. (2019) · HAL
A Review on Pathophysiology, Virulence, and Prophylactic Vaccination of Meningococcal Disease
Ahmed, S. O., Chavan, A. P., Chavan, D. L., Chonde, A. V., & Dakore, A. G. (2026) · Journal of Pharma Insights and Research. · doi:10.69613/g1jar134
Regassa, L. D., Assefa, N., Trotter, C. L., Lucidarme, J., Aiken, A. M., Oundo, J. O., Marami, D., Mohammed, F. A., Kebede, Y., Borrow, R., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-69519-x
MENINGITE MENINGOCÓCICA E VACINAÇÃO: DESAFIOS PARA A PREVENÇÃO DE SURTOS E O CONTROLE EPIDEMIOLÓGICO
KISCHENER, L. E., Sobrinho, P. C., Lutz, D. L., Silva, J. C. D. P. G., de Melo, A. A. V., Araújo, C. R. D. S., Ricarte, D. N., Pereira, P. M., & Mesquita, N. F. F. (2026) · South American Sciences · doi:10.63330/sasciencesv6n2-199
Wang, R., Wang, L., Nasronudin, N., Ahmed, S., Suharjanti, I., Romadhon, P. Z., Effendi, W. I., Purwaningsih, P., Rachman, B. E., Ari, Y., et al. (2026) · Vaccines · doi:10.3390/vaccines14110988
The role of glutamine synthetase in the pathogenesis of Neisseia meningitidis
Turner, I. (2020) · Nottingham ePrints (University of Nottingham)
Meningococcal Vaccine Clinical Trials
Martinon-Torres, F., Marshall, H. S., Murthy, A., Zolotas, L., & Beeslaar, J. F. (2026) · Springer eBooks · doi:10.1007/978-3-032-37993-1_9
Metadata
- Authors
- Maiden, M. C. J., Ibarz-Pavón, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'Aldeen, D. A. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., MacLennan, J., Cameron, J. C., & Stuart, J. M.
- Affiliations
- John Radcliffe Hospital (GB)
- Health Protection Agency (GB)
- Health Protection Agency Centre for Infections, London
- University of Southampton (GB)
- Bangor University (GB)
- National Public Health Service for Wales, Unit 1, Parc Nantgarw, Cardiff
- Imperial College London (GB)
- University of Nottingham (GB)
- Division of Microbiology, School of Molecular Medical Sciences, Institute of Infection Immunity and Inflammation University of Nottingham
- South West Peninsula Health Protection Unit, Lescaze Offices, Dartington, Devon
- Derriford Hospital (GB)
- University of Manchester (GB)
- Manchester Royal Infirmary (GB)
- Health Protection Scotland (GB)
- Corresponding author
- Maiden, Martin C J
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 197
- Issue
- 5
- Pages
- 737-743
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC6767871
- OpenAlex
- W2171028861
- Cited by
- 442
- References
- 41
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 9 · 2023: 16 · 2022: 10 · 2021: 21 · 2020: 18 · 2019: 21 · 2018: 29 · 2017: 32 · 2016: 24 · 2015: 40 · 2014: 22 · 2013: 28 · 2012: 45
- FWCI
- 35.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Wellcome Trust
- Scottish Executive Health Department
- Meningitis Trust
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- meningococcal serogroup C, conjugate vaccines, asymptomatic carriage, herd immunity, serogroup replacement, capsule expression, vaccine efficacy, young children, United Kingdom
- MeSH terms
- Adolescent, Adult, Carrier State, Cross-Sectional Studies, United Kingdom, Humans, Meningococcal Infections, Neisseria meningitidis, Serotyping, Meningococcal Vaccines, Immunity, Herd, Mass Vaccination, Neisseria meningitidis, Serogroup C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.